Boyangzi Li

629 total citations
25 papers, 485 citations indexed

About

Boyangzi Li is a scholar working on Surgery, Cell Biology and Biomedical Engineering. According to data from OpenAlex, Boyangzi Li has authored 25 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Cell Biology and 8 papers in Biomedical Engineering. Recurrent topics in Boyangzi Li's work include Proteoglycans and glycosaminoglycans research (9 papers), Cardiac Structural Anomalies and Repair (7 papers) and Mechanical Circulatory Support Devices (7 papers). Boyangzi Li is often cited by papers focused on Proteoglycans and glycosaminoglycans research (9 papers), Cardiac Structural Anomalies and Repair (7 papers) and Mechanical Circulatory Support Devices (7 papers). Boyangzi Li collaborates with scholars based in United States, Australia and Thailand. Boyangzi Li's co-authors include Robert J. Linhardt, Zhenqing Zhang, Fuming Zhang, Hiroo Takayama, Yoshifumi Naka, Jiho Han, Koji Takeda, Veli K. Topkara, Haiying Liu and P.C. Colombo and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Boyangzi Li

24 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boyangzi Li United States 11 197 169 135 130 59 25 485
G.E.C. Sims United Kingdom 6 95 0.5× 186 1.1× 171 1.3× 50 0.4× 77 1.3× 8 589
Pietro Bianchini Italy 12 78 0.4× 215 1.3× 144 1.1× 10 0.1× 41 0.7× 17 361
Xuewei Zhao China 15 140 0.7× 10 0.1× 249 1.8× 141 1.1× 68 1.2× 50 729
Shinichi Ohta Japan 13 75 0.4× 12 0.1× 105 0.8× 65 0.5× 7 0.1× 55 466
Zhijun Xu China 11 46 0.2× 42 0.2× 317 2.3× 50 0.4× 7 0.1× 28 558
Seong-Ho Kong South Korea 12 234 1.2× 42 0.2× 215 1.6× 81 0.6× 20 0.3× 40 723
Rui Zhong China 13 72 0.4× 30 0.2× 236 1.7× 23 0.2× 30 0.5× 37 491
Kazuyuki Hayashida Japan 8 39 0.2× 15 0.1× 122 0.9× 60 0.5× 14 0.2× 12 348
Stefan Bartsch Germany 10 105 0.5× 24 0.1× 194 1.4× 35 0.3× 13 0.2× 17 460

Countries citing papers authored by Boyangzi Li

Since Specialization
Citations

This map shows the geographic impact of Boyangzi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boyangzi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boyangzi Li more than expected).

Fields of papers citing papers by Boyangzi Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boyangzi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boyangzi Li. The network helps show where Boyangzi Li may publish in the future.

Co-authorship network of co-authors of Boyangzi Li

This figure shows the co-authorship network connecting the top 25 collaborators of Boyangzi Li. A scholar is included among the top collaborators of Boyangzi Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boyangzi Li. Boyangzi Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Boyangzi, Hayley B. Gershengorn, Emily A. Vail, et al.. (2025). Inotrope selection in mixed cardiogenic shock with sepsis: a comparative analysis between milrinone and dobutamine. Annals of the American Thoracic Society. 23(2). 252–260.
2.
Li, Boyangzi, Navneet Narula, C. Gidea, et al.. (2022). Missed Opportunities in Identifying Cardiomyopathy Aetiology Prior to Advanced Heart Failure Therapy. Heart Lung and Circulation. 31(6). 815–821. 3 indexed citations
3.
4.
Massera, Daniele, et al.. (2021). Mitral annular calcification in hypertrophic cardiomyopathy. International Journal of Cardiology. 349. 83–89. 10 indexed citations
5.
Li, Boyangzi, Navneet Narula, André L. Moreira, et al.. (2020). Cardiac AA amyloidosis in a patient with obstructive hypertrophic cardiomyopathy. Cardiovascular Pathology. 48. 107218–107218. 3 indexed citations
6.
Hausvater, Anaïs, Nathaniel R. Smilowitz, Boyangzi Li, et al.. (2020). Myocarditis in Relation to Angiographic Findings in Patients With Provisional Diagnoses of MINOCA. JACC. Cardiovascular imaging. 13(9). 1906–1913. 21 indexed citations
7.
Yoshioka, Daisuke, Boyangzi Li, Hiroo Takayama, et al.. (2017). Outcome of heart transplantation after bridge-to-transplant strategy using various mechanical circulatory support devices. Interactive Cardiovascular and Thoracic Surgery. 25(6). 918–924. 26 indexed citations
8.
Takeda, Koji, Boyangzi Li, Christine Mauro, et al.. (2017). Combined Therapy of Ventricular Assist Device and Membrane Oxygenator for Profound Acute Cardiopulmonary Failure. ASAIO Journal. 63(6). 713–719. 1 indexed citations
9.
Takeda, Koji, Boyangzi Li, A.R. Garan, et al.. (2016). Improved outcomes from extracorporeal membrane oxygenation versus ventricular assist device temporary support of primary graft dysfunction in heart transplant. The Journal of Heart and Lung Transplantation. 36(6). 650–656. 76 indexed citations
10.
Siracuse, Jeffrey J., et al.. (2014). External Carotid Artery Stenosis after Internal and Common Carotid Stenting. Annals of Vascular Surgery. 29(3). 443–446. 1 indexed citations
11.
Li, Boyangzi, et al.. (2012). Imaging the Glycome in Living Systems. Methods in enzymology on CD-ROM/Methods in enzymology. 505. 401–419. 8 indexed citations
12.
Garg, Hari G., Lunyin Yu, Charles A. Hales, et al.. (2011). Anti-proliferative effects of O-acyl-low-molecular-weight heparin derivatives on bovine pulmonary artery smooth muscle cells. Glycoconjugate Journal. 28(6). 419–426. 7 indexed citations
13.
Garg, Hari G., Lunyin Yu, Craig Freeman, et al.. (2010). Effect of carboxyl-reduced heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells. Carbohydrate Research. 345(9). 1084–1087. 7 indexed citations
14.
Yu, Lunyin, Hari G. Garg, Boyangzi Li, Robert J. Linhardt, & Charles A. Hales. (2010). Antitumor Effect of Butanoylated Heparin with Low Anticoagulant Activity on Lung Cancer Growth in Mice and Rats. Current Cancer Drug Targets. 10(2). 229–241. 20 indexed citations
15.
Li, Boyangzi, et al.. (2010). Analysis of Glycosaminoglycans in Stem Cell Glycomics. Methods in molecular biology. 690. 285–300. 12 indexed citations
16.
Zhang, Zhenqing, Boyangzi Li, Preeyanat Vongchan, et al.. (2009). Sulfonation of papain-treated chitosan and its mechanism for anticoagulant activity. Carbohydrate Research. 344(10). 1190–1196. 51 indexed citations
17.
Zhang, Zhenqing, Boyangzi Li, Fuming Zhang, et al.. (2009). Analysis of pharmaceutical heparins and potential contaminants using 1H-NMR and PAGE. Journal of Pharmaceutical Sciences. 98(11). 4017–4026. 69 indexed citations
18.
Li, Boyangzi, Fuming Zhang, Zhenqing Zhang, et al.. (2009). Oversulfated chondroitin sulfate interaction with heparin-binding proteins: New insights into adverse reactions from contaminated heparins. Biochemical Pharmacology. 78(3). 292–300. 68 indexed citations
19.
Garg, Hari G., Lunyin Yu, Craig Freeman, et al.. (2008). Significance of the 2-O-sulfo group of l-iduronic acid residues in heparin on the growth inhibition of bovine pulmonary artery smooth muscle cells. Carbohydrate Research. 343(14). 2406–2410. 8 indexed citations
20.
Park, Youmie, Zhenqing Zhang, Tatiana N. Laremore, et al.. (2008). Variation of acharan sulfate and monosaccharide composition and analysis of neutral N-glycans in African giant snail (Achatina fulica). Glycoconjugate Journal. 25(9). 863–877. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G.E.C. Sims Breakdown of academic impact, for papers by Pietro Bianchini Breakdown of academic impact, for papers by Xuewei Zhao Breakdown of academic impact, for papers by Shinichi Ohta Breakdown of academic impact, for papers by Zhijun Xu Breakdown of academic impact, for papers by Seong-Ho Kong Breakdown of academic impact, for papers by Rui Zhong Breakdown of academic impact, for papers by Kazuyuki Hayashida Breakdown of academic impact, for papers by Stefan Bartsch
Rankless by CCL
2026